Johnson & Johnson (JNJ)
NASDAQ • Healthcare
January 21, 2026 at 21:00 UTC
Name
CEO
Website
Industry
Year Founded
Employees
Johnson & Johnson is a healthcare company that develops medicines and medical technologies for use in clinical practice. Its model connects research, manufacturing, and patient access so therapies and devices move from trials to everyday care under consistent standards. Teams focus on areas where long-term treatment and careful procedure matter, pairing evidence with clear guidance for clinicians. Supply and quality systems favor steady availability over splashy launches, and education helps professionals apply products safely. Operations span many regions, but the promise is the same: dependable options that fit real care settings and can be supported for the long run. The emphasis is safety, labeling clarity, and continuity in daily use.
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Johnson & Johnson's Technical Indicators Summary
Johnson & Johnson’s current price near $219 reflects a strong bullish trend, supported by solid momentum indicators such as a high RSI close to 70 and a robust MACD level signaling buying pressure. The ADX suggests an emerging trend strength above the threshold, reinforcing the upward momentum. Price remains well above key moving averages across short, medium, and long terms, indicating sustained upward support. While volatility is moderate, as shown by the average true range, volume patterns confirm accumulation with a rising On-Balance Volume. Despite some overbought signals from oscillators like the Stochastic and Williams %R, the overall technical picture remains positive. The technical takeaway is a resilient uptrend marked by strong momentum and trend confirmation.
| Indicator | Value |
|---|---|
RSI (14) | 69.26 |
Stochastic %K (14, 3, 3) | 96.59 |
CCI (20) | 210.88 |
WPR (14) | -7.55 |
Momentum (10) | 11.31 |
MFI | 67.51 |
MACD Level (12, 26) | 3.24 |
Bollinger Bands | $199.43 - $218.45 |
ATR (14) | $3.60 (1.65%) |
ADX (14) | 25.67 |
OBV | 382,375,600 |
Exponential Moving Averages | $181.00 - $212.94(5 indicators) |
Simple Moving Averages | $176.56 - $210.69(5 indicators) |
Get premium market insights delivered directly to your inbox.
At the bell, JNJ slid into a -3.304% gap down, opening at 211.00 versus yesterday’s close. As trading begins, JNJ is setting up ahead of a print on 2026-01-21 (0 days away), with early price at 215.69. JNJ's slide follows earnings beat but sales decline of Stelara weighed on investor sentiment amid mixed headlines.
Price Change
from $218.21 close
$-2.52
Trading Volume
Below avg (9.6M)
4.5M
vs S&P 500 Today
Strong Underperformance
-3.38%
52-Week Position
Near highs
94.4%
Updated: January 21, 2026 at 15:43 UTC
Biotech & AI Fuel Big Stock Moves
January 20, 2026
Cramer Weighs In on Big Banks, Tech and Staples
January 18, 2026
Dow Hits Record High Amid Shutdown Optimism, Tech Stocks Slide
November 12, 2025